Shenzhen Neptunus Interlong Renews Sales Framework Agreement with Neptunus Group

Reuters2025-10-30

Shenzhen Neptunus Interlong Renews Sales Framework Agreement with Neptunus Group

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. announced the renewal of the Neptunus Group Sales Framework Agreement with Shenzhen Neptunus Group Company Limited. Under the new agreement, the company will continue to sell certain self-manufactured or distributed products, including pharmaceutical products, healthcare food products, and medical devices, to the Neptunus Group for the period up to 31 December 2028. The announcement also sets out the proposed 2028 sales cap, representing the estimated maximum aggregate sales amount for that year. The agreement constitutes a continuing connected transaction, and certain directors of the company hold positions within the Neptunus Group and its subsidiaries. The renewal and terms of the agreement are subject to relevant regulatory requirements and independent shareholder approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. published the original content used to generate this news brief on October 30, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2579611384?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-30 17:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579611384","market":"us","top_or_hot":-1,"title":"Shenzhen Neptunus Interlong Renews Sales Framework Agreement with Neptunus Group","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Shenzhen Neptunus Interlong Renews Sales Framework Agreement with Neptunus Group\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. announced the renewal of the Neptunus Group Sales Framework Agreement with Shenzhen Neptunus Group Company Limited. Under the new agreement, the company will continue to sell certain self-manufactured or distributed products, including pharmaceutical products, healthcare food products, and medical devices, to the Neptunus Group for the period up to 31 December 2028. The announcement also sets out the proposed 2028 sales cap, representing the estimated maximum aggregate sales amount for that year. The agreement constitutes a continuing connected transaction, and certain directors of the company hold positions within the Neptunus Group and its subsidiaries. The renewal and terms of the agreement are subject to relevant regulatory requirements and independent shareholder approval.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. published the original content used to generate this news brief on October 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shenzhen Neptunus Interlong Renews Sales Framework Agreement with Neptunus Group</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShenzhen Neptunus Interlong Renews Sales Framework Agreement with Neptunus Group\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-30 17:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Shenzhen Neptunus Interlong Renews Sales Framework Agreement with Neptunus Group\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. announced the renewal of the Neptunus Group Sales Framework Agreement with Shenzhen Neptunus Group Company Limited. Under the new agreement, the company will continue to sell certain self-manufactured or distributed products, including pharmaceutical products, healthcare food products, and medical devices, to the Neptunus Group for the period up to 31 December 2028. The announcement also sets out the proposed 2028 sales cap, representing the estimated maximum aggregate sales amount for that year. The agreement constitutes a continuing connected transaction, and certain directors of the company hold positions within the Neptunus Group and its subsidiaries. The renewal and terms of the agreement are subject to relevant regulatory requirements and independent shareholder approval.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. published the original content used to generate this news brief on October 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL3l7z7p:1","article_id":"2579611384","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579611384","pubTimestamp":1761817191,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. announced the renewal of the Neptunus Group Sales Framework Agreement with Shenzhen Neptunus Group Company Limited. Under the new agreement, the company will continue to sell certain self-manufactured or distributed products, including pharmaceutical products, healthcare food products, and medical devices, to the Neptunus Group for the period up to 31 December 2028. The announcement also sets out the proposed 2028 sales cap, representing the estimated maximum aggregate sales amount for that year. The agreement constitutes a continuing connected transaction, and certain directors of the company hold positions within the Neptunus Group and its subsidiaries. The renewal and terms of the agreement are subject to relevant regulatory requirements and independent shareholder approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely infor","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","BK0188":"融资融券","BK0168":"禽流感","000078":"海王生物","BK0060":"抗癌","08329":"海王英特龙","BK0028":"国家队","BK0209":"零售"},"translate_title":"深圳海王英特隆与海王集团续签销售框架协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000078":0.9,"08329":0.9},"content_text":"Shenzhen Neptunus Interlong Renews Sales Framework Agreement with Neptunus Group\n    \n\n        Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. announced the renewal of the Neptunus Group Sales Framework Agreement with Shenzhen Neptunus Group Company Limited. Under the new agreement, the company will continue to sell certain self-manufactured or distributed products, including pharmaceutical products, healthcare food products, and medical devices, to the Neptunus Group for the period up to 31 December 2028. The announcement also sets out the proposed 2028 sales cap, representing the estimated maximum aggregate sales amount for that year. The agreement constitutes a continuing connected transaction, and certain directors of the company hold positions within the Neptunus Group and its subsidiaries. The renewal and terms of the agreement are subject to relevant regulatory requirements and independent shareholder approval.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. published the original content used to generate this news brief on October 30, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2579611384","isCrawlerRequest":true}